Cargando…
Corneal Epithelial Toxicity after Intravitreal Methotrexate Injection for Vitreoretinal Lymphoma: Clinical and In Vitro Studies
Methotrexate is widely used as an intraocular chemotherapy for vitreoretinal lymphoma (VRL). Although corneal toxicity has been reported in patients after intravitreal methotrexate injections, the incidence, outcome, and mechanism of the toxicity are unclear. Herein, we performed a clinical study to...
Autores principales: | Jeong, Yoon, Ryu, Jin Suk, Park, Un Chul, Oh, Joo Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463496/ https://www.ncbi.nlm.nih.gov/pubmed/32824794 http://dx.doi.org/10.3390/jcm9082672 |
Ejemplares similares
-
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
por: Zhou, Xian, et al.
Publicado: (2020) -
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
por: Anthony, Casey L., et al.
Publicado: (2021) -
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
por: Jiang, Tingting, et al.
Publicado: (2022) -
Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
por: Cheng, Chieh‐Lung, et al.
Publicado: (2023) -
Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence
por: Park, Young Gun, et al.
Publicado: (2020)